On May 3, 2023, a New Jersey appellate court made a landmark decision in favor of Merck & Co Inc (NYSE:MRK) in a $1.4 billion cyberattack coverage case. The court ruled that a group of insurers cannot use war as an argument to deny Merck coverage from the cyberattack that happened in 2017. The…
Source: beststocks.com – Read more
New Jersey Court Rules in Favor of Merck in Cyberattack Coverage Case


Must Read
HIMSS23 Europe: Promoting patient trust in health data sharing
Patient involvement is vital in creating the new digital world of healthcare, but often citizens often feel fear and distrust about the use of...